The current study demonstrated that in colon cancer, TADC-derived CXCL1 promotes expression of high levels of the PTHLH transcript and its protein, which are negatively correlated with relapse-free and overall survival rates in colon cancer. The gene discussed is PTHLH; the disease is colonic neoplasm.